That's correct.
Thanks, Chair. I wouldn't mind if you gave us a signal at two and a half minutes.
Thanks, Minister, for being here.
Also, Mr. Knubley, it's good to see you again.
Mr. Da Pont, congratulations on your relatively new position. It's nice to see you here.
With regard to the very recent tariff reduction on apple juice concentrate, I'm wondering if you've analyzed the impact of that on our fruit growers. That's my first question.
Second is a follow up on my November 7 letter to you, Mr. Da Pont, on the subject of horse meat. There are some health concerns. Horses aren't raised for food production. They often have a significant degree of banned medication, such as phenylbutazone, which we do not allow in meat for human consumption. There have been studies, such as the one in the Irish Veterinary Journal, showing that this drug causes anaplastic anemia in children. The EU now stamps new equine passports issued to horses over the age of six months indicating that they are ineligible for its food supply. We import something like 50,000 horses for slaughter in this country, 85% of which have probably taken some drugs in their lifetime.
Specifically, I'm wondering what percentage of the drug testing we do is performed on equine organs. What is the methodology and specific testing mechanism that we use to ensure that this meat coming out of our horse slaughter plants is safe and that it doesn't contain phenylbutazone? Are the equine identity documents kept on record by slaughter plants, and are they being edited by CFIA for accuracy and possible fraud?
If you don't have the exact answers here, Mr. Da Pont, I certainly wouldn't mind it if you threw them into a response to me. I'll stop there.